About this trial
Phase 1 trial
Patient Profile
Paediatric CD22 positive acute lymphocytic leukemia (ALL).
Where’s this trial being run?
Crumlin Children’s Hospital
Can I join this study / trial?
The first step we recommend is to talk to your doctor or the cancer trials team at your hospital. You can find contact details for cancer trials research units in Ireland here.
It’s also a good idea to print this page and bring it with you to your appointment. It can help guide the conversation and remind you of what to ask. You may also want to talk to your family or friends about your options, as they can offer support as you make decisions.
For more detailed information
Click HereQuestions?
Here’s a list of questions you may have for your doctor or local cancer research team.
QuestionsSummary Data
| Name: | ITCC 059 |
|---|---|
| Number: | 18-16 |
| Full Title: | A Phase 1 study of Inotuzumab Ozogamycin as a single agent and in combination with chemotherapy for paediatric CD22-Positive ALL |
| Principal Investigator: | Dr Owen Smith |
|---|---|
| Type: | Collaborative |
| Sponsor: | Erasmus Medical Centre |
| Recruitment Started: |
Global: Not Available Ireland: Not Available |
| Global Recruitment Target: | Not Available |
|---|---|
| Ireland Recruitment Target: | Not Available |